Abstract
In recent years, attempts have been made to alter the course of neoplasia by augmenting host defense mechanisms. A number of adjuvants including bacterial vaccines and chemical compounds have been demonstrated to produce a nonspecific stimulation of the reticuloendothelial (RE) system and augment humoral and cellular immune response. The most commonly employed agents are Bacillus Calmette-Guerin (BCG) and Corynebacterium parvum (16,22). The efficacy of such nonspecific immunotherapy, however, varies depending upon the time and mode of injection (4,29,31) as well as the type of malignancy (29,33). In view of the virulent and antigeneic nature of bacterial adjuvants such as BCG, it is not surprising that complications have been observed on occasion following the intratumoral or intradermal injections of these agents (22,32). Furthermore, there is the threat of disseminated infection following inoculation with viable organisms in patients with immunodeficiency states secondary to malignancy (22) or in immunosuppressed animals (25). Indeed, Sparks, et al. (35) reported that rats receiving isonicotinic acid hydrazine and BCG intralesionally had better survival and smaller tumor volumes than BCG alone, possibly by inhibiting diversion of host response to the viable BCG organism.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Ashworth, C. T., Di Luzio, N. R. and Riggi, S. J., Exp. Mol. Pathol. 1 (1963) 83.
Browder, W., Cohen, C., McNamee, R., Hoffmann, E. 0. and Di Luzio, N. R., In: Immune Modulation and Control of Neoplasia by Adjuvant Therapy (Ed. M. A. Chirigos ), Raven Press, New York, (1978) 207.
Burgaleta, C. and Golde, D., Can. Res. 37 (1977) 1739.
Chee, D. O. and Bodurtha, A. J., Int. J. Cancer 14 (1974) 137.
Di Luzio, N. R., McNamee, R., Miller, E. F. and Pisano, J. C., J. Reticuloendothel. Soc. 12 (1972) 314.
Di Luzio, N. R., Pharmacology of the reticuloendothelial system: Accent on Glucan. The Reticuloendothelial System in Health and Disease, (Eds. S. Reichard, M. Escobar and H. Friedman ), Plenum Press, New York, (1976) 412.
Di Luzio, N. R., Influence of glucan on hepatic metastases. In: Kupffer Cells and Other Liver Sinusoidal Cells, (Eds. E. Wisse and D. L. Knook ), Elsevier/N Holland Biomed. Press, Amsterdam, (1977) 397.
Di Luzio, N. R., Cook, J. A., Cohen, C., Rodrigue, J. and Jones, E., The synergistic effect of cyclophosphamide and glucan on experimental acute myelogenous and lymphocytic leukemia. In: The Macrophage and Cancer, (Eds. K. James, B. McBride, A. Stuart ), Econoprint, Scotland, (1977a) 188.
Di Luzio, N. R., Hoffmann, E. O., Cook, J. A., Browder, W. and Mansell, P. W. A., Glucan induced enhancement in host resistance to experimental tumors. In: Control of Neoplasia by Modulation of the Immune System, (Ed. M. Chirigos ), Raven Press, New York, (1977b) 475.
Di Luzio, N. R., Cook, J. A., Cohen, C., Rodrigue, J., Kokoshis, P. and McNamee, R., Enhancement of the inhibitory effect of cyclophosphamide on experimental acute myelogenous leukemia by glucan immunopotentiation and the response of serum lysozyme, (Ed. M. Chirigos ), Raven Press, New York, (1978) 171.
Di Luzio, N. R., Lysozyme activity: An index of macrophage functional status. In: Lysosomes in Biology and Pathology (1978) in press.
Di Luzio, N. R., McNamee, R., Browder, W. and Williams, D., Cancer Tr. Resp. (1978) in press.
Gilbert, K., Chu, F., Jones, E. and Di Luzio, N. R., J. Reticuloendothel. Soc. 22 (1977) 319.
Glovsky, M. M., Di Luzio, N. R., Alenty, A. and Ghekiere, L., J. Reticuloendothel. Soc. 20 (1977) 54a.
Golde, D. W. and Burgaleta, C., Glucan-activated macrophages: Functional properties and cytotoxicity against syngeneic leukemia cells. In: Immune Modulation and Control of Neoplasia by Adjuvant Therapy, (Ed. M. A. Chirigos ), Raven Press, New York, (1978) 201.
Halpern, B., Corynebacterium parvum: Applications in experimental and clinical oncology, Plenum Press, London (1975).
Hassid, W. Z., Joslyn, M. A., McCready, R. M., J. Am. Chem. Soc. 63 (1941) 295.
Hibbs, J. B., Taintor, R. R., Chapman, H. A., Jr. and Weinberg, J. B., Science 197 (1977) 279.
Hunter, J. T., Meltzer, M. S., Ribi, E., Fidler, I. J., Hanna, M. G., Jr. and Rapp, H. J., J. Natl. Cancer Inst. 60 (1978) 419.
Israel, L. and Edelstein, R., Treatment of cutaneous and subcutaneous metastatic tumors with intralesional glucan. In: Immune Modulation and Control of Neoplasia by Adjuvant Therapy, (Ed. M. A. Chirigos ), Raven Press, New York, (1978) 249.
Kokoshis, P. L., Williams, D. L., Cook, J. A. and Di Luzio, N. R., Science 199 (1978) 1340.
Lemoureux, G., Turcotte, R. and Portelance, V., BCG in cancer immunotherapy, Grune and Stratton, New York, (1976).
Lampert, I. A., Jones, P. A., Salder, T. E. and Castro, J. E., Br. J. Cancer 36 (1977) 51.
Lemonde, P., Natl. Cancer Inst. Monogr. 39 (1973) 21.
Lemonde, P., Ambivalent effects of BCG in experimental neoplasms. In: BCG in Cancer Immunotherapy, (Eds. G. Lamoureus, R. Turcotte, V. Portelance ), Grune and Stratton, New York, (1976) 155.
Mansell, P. W. A., Ichinose, H., Reed, R. J., Krementz, E. T., McNamee, R. and Di Luzio, N. R., J. Natl. Cancer Inst. 54 (1975) 571.
Mansell, P. W. A., Di Luzio, N. R., McNamee, R., Rowden, G. and Proctor, J. W., Ann. NY Acad. Sci. 277 (1976) 20.
Mansell, P. W. A., Roweden, G. and Hammer, D., Clinical experiences with the use of glucan. In: Immune Modulation and Control of Neoplasia by Adjuvant Therapy, (Ed. M. A. Chirigos ), Raven Press, New York, (1978) 255.
Mazurek, C., Chaluet, H., Stiffel, C. and Giozzi, G., Br. J. Can. 17 (1976) 511.
Old, L. J., Benacerraf, B., Clarke, D. A., Carswell, E. A. and Stockert, E., Cancer Res. 21 (1961). 1281.
Pimm, M. V. and Baldwin, R. W., Int. J. Cancer 15 (1975) 260.
Proctor, J. W., Lewis, M. G. and Mansell, P. W. A., Ca. J. Surg. 19 (1976) 12.
Roumiantzell, M., Musetescu, M., Ayme, G. and Mynard, M. C., Effect of inactived Corynebacterium on different experimental tumors in mice. In: Corynebacterium parvum, (Ed. B. Halpern ), Plenum Press, London, (1974) 202.
Schultz, R. M., Papamatheakis, J. D. and Chirigos, M. A., Tumoricidal effect in vitro of peritoneal macrophages from mice treated with glucan. In: Immune Modulation and Control of Neoplasia by Adjuvant Therapy, (Ed. M. A. Chirigos ), Raven Press, New York, (1978) 241.
Sparks, F., Albert, N. and Breeding, J., J. Natl. Cancer Inst., 58 (1977) 367.
Ungargo, P. C., Drake, W. P. and Mardiney, M. R., Jr., J. Natl. Cancer Inst. 50 (1973) 125.
Wooles, W. R. and Di Luzio, N. R., Am. J. Physiol. 203 (1962) 404.
Wooles, W. R. and Di Luzio, N. R., Science 142 (1963) 1078.
Wooles, W. R. and Di Luzio, N. R., J. Reticuloendothel. Soc., I (1964) 160.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1980 Plenum Press, New York
About this chapter
Cite this chapter
di Luzio, N.R., Mcnamee, R.B., Williams, D.L., Gilbert, K.M., Spanjers, M.A. (1980). Glucan Induced Inhibition of Tumor Growth and Enhancement of Survival in a Variety of Transplantable and Spontaneous Murine Tumor Models. In: Escobar, M.R., Friedman, H. (eds) Macrophages and Lymphocytes. Advances in Experimental Medicine and Biology, vol 121B. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-3593-1_24
Download citation
DOI: https://doi.org/10.1007/978-1-4684-3593-1_24
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-3595-5
Online ISBN: 978-1-4684-3593-1
eBook Packages: Springer Book Archive